CORONA Remedies
Ticker > Company >

CORONA Remedies share price

CORONA Remedies Ltd.

NSE: CORONA BSE: 544644 SECTOR: Pharmaceuticals & Drugs  82   0   0

1448.05
0 0
BSE: Today, 01:57 PM

Price Summary

Today's High

₹ 1499

Today's Low

₹ 1420

52 Week High

₹ 0

52 Week Low

₹ 0

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationAttractive
The stock is considerably attractive based on intrinsic value.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 8856.29 Cr.

Enterprise Value

₹ 8849.71 Cr.

No. of Shares

6.12 Cr.

P/E

59.42

P/B

14.62

Face Value

₹ 10

Div. Yield

0.5 %

Book Value (TTM)

₹  99.04

CASH

₹ 69.27 Cr.

DEBT

₹ 62.69 Cr.

Promoter Holding

-

EPS (TTM)

₹  24.37

Sales Growth

0

ROE

ROCE

Profit Growth

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year17.93%
3 Year24.68%
5 YearNA

Profit Growth

1 Year64.7%
3 Year620.88%
5 YearNA

ROE%

1 Year27.45%
3 Year23.69%
5 Year18.34%

ROCE %

1 Year32.55%
3 Year29.51%
5 Year22.8%

Debt/Equity

0.1035

Price to Cash Flow

46.49

Interest Cover Ratio

0

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Investors List
 Share Holding Data is not available for this company.Report us
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good revenue growth of 24.6772521227509% for the Past 3 years.
  • The company has significantly decreased its debt by 71.4467 Cr.
  • Company has been maintaining healthy ROE of 23.6919333333333% over the past 3 years.
  • Company has been maintaining healthy ROCE of 29.5065333333333% over the past 3 years.
  • The company has an efficient Cash Conversion Cycle of 0 days.

 Limitations

  • Company has low Interest coverage ratio of 0.
  • The company has a low EBITDA margin of 0% over the past 5 years.
  • The company is trading at a high EV/EBITDA of 36.3453.

Quarterly Result (All Figures in Cr.)
 Quarterly Data is not available for this company.Report us

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 576.16 617.33 884.05 1014.47 1196.42
Total Expenditure 470.78 599.51 756.07 859.74 956.44
Operating Profit 105.39 17.82 127.98 154.74 239.98
Other Income 4.94 6.6 7.05 6.46 5.94
Interest 2.01 4.73 4.27 14.44 10.6
Depreciation 15.89 20.48 20.1 28.28 37.16
Exceptional Items 0 0 0 0 0
Profit Before Tax 92.43 -0.8 110.66 118.48 198.15
Tax 22.49 -0.4 25.96 27.98 49.1
Net Profit 69.95 -0.4 84.7 90.5 149.05
Adjusted EPS (Rs.) 13.7 -0.3 13.85 14.8 24.37

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 5.03 51.05 61.55 61.16 61.16
Total Reserves 332.8 269.86 346.75 419.02 544.57
Borrowings 31.82 16.54 0 67 16
Other N/C liabilities 23.09 22.29 44.88 58.98 67.92
Current liabilities 191.47 193.92 209.26 268.81 327.1
Total Liabilities 584.21 553.65 662.43 874.96 1016.75
Assets
Net Block 164.4 161.76 184.6 383.7 369.88
Capital WIP 0 14.23 64.71 120.59 185.95
Intangible WIP 0 0 0 0 0
Investments 7.06 7.07 25.3 25.31 25.33
Loans & Advances 1.18 4.21 9.54 8.56 9.1
Other N/C Assets 29 36.71 14.91 2.26 0.1
Current Assets 382.57 329.68 363.38 334.54 426.38
Total Assets 584.21 553.65 662.43 874.96 1016.75
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 92.43 -0.8 110.66 118.48 198.15
Adjustment 28.87 20.34 22.78 46.87 52.69
Changes in Assets & Liabilities -14.53 79.66 -4.91 9.32 -17.06
Tax Paid -27.61 -1.5 -25.82 -17.91 -43.28
Operating Cash Flow 79.16 97.71 102.7 156.76 190.49
Investing Cash Flow -102.12 -65.81 -50.28 -266.64 -83.84
Financing Cash Flow 0.09 -29.86 -44.75 98.54 -106.59
Net Cash Flow -22.86 2.04 7.67 -11.34 0.07

Corporate Actions

Investors Details

 No Promoters Data available for this company.Report us
 No Investors Data available for this company.Report us

Annual Reports

Title Link
Title Link
 No Annual reports exist for this company.Report us

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit and Research reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation and Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us
Last Updated on:
Brief about CORONA Remedies
X